Ceftazidime Injection — FDA Drug Shortage
The FDA lists a drug shortage record for Ceftazidime Injection (injection) from Hospira, Inc., A Pfizer Company with status To Be Discontinued. The shortage was first posted on Nov 14, 2025.
Shortage details
- Status
- To Be Discontinued
- Company
- Hospira, Inc., A Pfizer Company
- Package NDC
- 0409-5092-16
- Dosage Form
- Injection
- Presentation
- Tazicef, Injection, 1 g (NDC 0409-5092-16)
- Initial Posting
- Nov 14, 2025